SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001618835-22-000166
Filing Date
2022-08-12
Accepted
2022-08-12 17:22:31
Documents
65
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q evfm-20220630.htm   iXBRL 10-Q 2127892
2 EX-10.5 exhibit105.htm EX-10.5 113272
3 EX-31.1 evfm-6302022xex311.htm EX-31.1 19868
4 EX-31.2 evfm-6302022xex312.htm EX-31.2 19730
5 EX-32.1 evfm-6302022xex321.htm EX-32.1 10945
  Complete submission text file 0001618835-22-000166.txt   10202446

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evfm-20220630.xsd EX-101.SCH 57753
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT evfm-20220630_cal.xml EX-101.CAL 70713
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evfm-20220630_def.xml EX-101.DEF 412668
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evfm-20220630_lab.xml EX-101.LAB 714583
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evfm-20220630_pre.xml EX-101.PRE 494389
59 EXTRACTED XBRL INSTANCE DOCUMENT evfm-20220630_htm.xml XML 1914259
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36754 | Film No.: 221161321
SIC: 2834 Pharmaceutical Preparations